BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 23620106)

  • 1. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
    Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
    BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy.
    Roeleveld DM; Koenders MI
    Cytokine; 2015 Jul; 74(1):101-7. PubMed ID: 25466295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis.
    Kugyelka R; Kohl Z; Olasz K; Mikecz K; Rauch TA; Glant TT; Boldizsar F
    Mediators Inflamm; 2016; 2016():6145810. PubMed ID: 26903711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis.
    Benedetti G; Miossec P
    Eur J Immunol; 2014 Feb; 44(2):339-47. PubMed ID: 24310226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics.
    van den Berg WB; McInnes IB
    Semin Arthritis Rheum; 2013 Oct; 43(2):158-70. PubMed ID: 24157091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation.
    Ye L; Jiang B; Deng J; Du J; Xiong W; Guan Y; Wen Z; Huang K; Huang Z
    J Immunol; 2015 Jun; 194(11):5110-9. PubMed ID: 25917106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
    Yamagata T; Skepner J; Yang J
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
    Zhu S; Qian Y
    Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Th17 cells in autoimmune diseases.
    Yang J; Sundrud MS; Skepner J; Yamagata T
    Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IL-17 pathway as a major therapeutic target in autoimmune diseases.
    Hu Y; Shen F; Crellin NK; Ouyang W
    Ann N Y Acad Sci; 2011 Jan; 1217():60-76. PubMed ID: 21155836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.
    Toussirot E
    Inflamm Allergy Drug Targets; 2012 Apr; 11(2):159-68. PubMed ID: 22280236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.
    Azizi G; Jadidi-Niaragh F; Mirshafiey A
    Int J Rheum Dis; 2013 Jun; 16(3):243-53. PubMed ID: 23981743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis.
    van Hamburg JP; Tas SW
    J Autoimmun; 2018 Feb; 87():69-81. PubMed ID: 29254845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17/Th17 mediated synovial inflammation is IL-22 independent.
    van Hamburg JP; Corneth OB; Paulissen SM; Davelaar N; Asmawidjaja PS; Mus AM; Lubberts E
    Ann Rheum Dis; 2013 Oct; 72(10):1700-7. PubMed ID: 23328939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.
    Schinnerling K; Aguillón JC; Catalán D; Soto L
    Clin Exp Immunol; 2017 Jul; 189(1):12-20. PubMed ID: 28369786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis.
    Paulissen SM; van Hamburg JP; Dankers W; Lubberts E
    Cytokine; 2015 Jul; 74(1):43-53. PubMed ID: 25828206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune inflammation from the Th17 perspective.
    Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
    Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases.
    Kuwabara T; Ishikawa F; Kondo M; Kakiuchi T
    Mediators Inflamm; 2017; 2017():3908061. PubMed ID: 28316374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting RORγt/Th17 axis for autoimmune disorders.
    Isono F; Fujita-Sato S; Ito S
    Drug Discov Today; 2014 Aug; 19(8):1205-11. PubMed ID: 24792721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of IL-17 and IL-22 in autoimmunity and cancer.
    Blake SJ; Teng MW
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.